Main > ONCOLOGY (**) > Leukemia>Lymphocytic>Chronic>HCT> > Co: USA. A. cGVHD>Treat.>Ibrutinib.

---

Co: USA. A. cGVHD>Treat.>Ibrutinib.'s subsections
(*) USA Approval Date: 2017. 08.02.
>After Failure of >1 Lines of>
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 33
Patent>UpDate: 2018. 11.06.
TradeMark
TradeMark Web-Site

Co: USA. A. cGVHD>Treat.>Ibrutinib.'s products
This section has no products